NYSE - Delayed Quote • USD
At close: 4:00 PM EDT
After hours: 5:29 PM EDT
Line
Candle
Baseline
Mountain
Bar
Loading Chart for TMO
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
575.28 - Open
575.29 - Bid --
- Ask --
- Day's Range
572.05 - 581.66 - 52 Week Range
415.60 - 603.82 - Volume
1,119,087 - Avg. Volume
1,347,626 - Market Cap (intraday)
221.334B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
37.19 - EPS (TTM)
15.59 - Earnings Date Jul 24, 2024 - Jul 29, 2024
- Forward Dividend & Yield 1.56 (0.27%)
- Ex-Dividend Date Jun 14, 2024
- 1y Target Est
626.25
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
122,000
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Thermo Fisher Scientific Inc.
Recent News: TMO
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: TMO
Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is
YTD Return
TMO
9.31%
S&P 500
12.23%
1-Year Return
TMO
12.11%
S&P 500
25.25%
3-Year Return
TMO
30.11%
S&P 500
26.55%
5-Year Return
TMO
113.53%
S&P 500
89.41%
Compare To: TMO
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
579.84
+0.79%
Mkt Cap 221.334B
Industry Diagnostics & Research
267.98
+0.05%
Mkt Cap 198.489B
Industry Diagnostics & Research
132.82
-0.55%
Mkt Cap 38.752B
Industry Diagnostics & Research
300.55
-2.16%
Mkt Cap 17.829B
Industry Diagnostics & Research
114.72
+7.42%
Mkt Cap 18.274B
Industry Diagnostics & Research
497.84
+0.40%
Mkt Cap 41.115B
Industry Diagnostics & Research
403.09
-1.15%
Mkt Cap 12.489B
Industry Diagnostics & Research
1,438.03
-0.96%
Mkt Cap 30.713B
Industry Diagnostics & Research
220.49
+0.73%
Mkt Cap 40.173B
Industry Diagnostics & Research
322.02
-2.31%
Mkt Cap 26.626B
Industry Diagnostics & Research
44.67
-1.93%
Mkt Cap 8.243B
Industry Diagnostics & Research
Statistics: TMO
Valuation Measures
As of 6/5/2024
Market Cap
219.59B
Enterprise Value
247.95B
Trailing P/E
36.90
Forward P/E
26.60
PEG Ratio (5yr expected)
2.31
Price/Sales (ttm)
5.24
Price/Book (mrq)
4.82
Enterprise Value/Revenue
5.84
Enterprise Value/EBITDA
21.86
Financial Highlights
Profitability and Income Statement
Profit Margin
14.20%
Return on Assets (ttm)
4.82%
Return on Equity (ttm)
13.62%
Revenue (ttm)
42.49B
Net Income Avi to Common (ttm)
6.03B
Diluted EPS (ttm)
15.59
Balance Sheet and Cash Flow
Total Cash (mrq)
7.25B
Total Debt/Equity (mrq)
78.17%
Levered Free Cash Flow (ttm)
6.07B
Research Analysis: TMO
Company Insights: TMO
Research Reports: TMO
People Also Watch
DHR Danaher Corporation
267.98
+0.05%
SYK Stryker Corporation
349.63
+1.05%
ZTS Zoetis Inc.
176.78
+0.55%
UNH UnitedHealth Group Incorporated
501.92
-0.24%
BDX Becton, Dickinson and Company
240.17
+1.64%
ILMN Illumina, Inc.
114.72
+7.42%
ISRG Intuitive Surgical, Inc.
418.15
+0.22%
REGN Regeneron Pharmaceuticals, Inc.
1,000.79
-0.51%
ABT Abbott Laboratories
104.27
+1.01%
VRTX Vertex Pharmaceuticals Incorporated
485.53
+0.52%
EW Edwards Lifesciences Corporation
87.68
+0.70%
MDT Medtronic plc
82.34
+0.04%
NOW ServiceNow, Inc.
703.16
-0.13%
SPGI S&P Global Inc.
434.66
-0.37%
LLY Eli Lilly and Company
837.29
+0.66%
UNP Union Pacific Corporation
228.31
+0.40%